Amarin Corp Plcuk (AMRN) Inventory Average (2012 - 2026)
Amarin Corp Plcuk (AMRN) posted quarterly Inventory Average of $189.8 million for Q1 2026, up 16.58% YoY from $162.8 million in Q1 2025, and little changed sequentially from $190.3 million in Q4 2025.
Amarin Corp Plcuk (AMRN) Inventory Average (2012 - 2026) Analysis & Trends
Amarin Corp Plcuk has disclosed Inventory Average across 15 years of filings, most recently posting $189.8 million for Q1 2026.
- In Q1 2026, Inventory Average rose 16.58% year-over-year to $189.8 million; the TTM figure through Mar 2026 stood at $189.8 million (up 16.58% YoY), while the FY2025 annual figure was $181.0 million, down 14.77% from the prior year.
- Inventory Average steadied at $189.8 million in Q1 2026, from $190.3 million in the prior quarter.
- Over the last five years, Inventory Average for AMRN reached as high as $256.9 million in Q1 2024 and fell as low as $162.8 million in Q1 2025.
- The 5-year median for Inventory Average is $227.3 million (2023), against an average of $218.9 million.
- Annual changes were most pronounced in 2022 — Inventory Average climbed 19.71% — and 2025, when it tumbled 36.65%.
- A 5-year view of Inventory Average shows it stood at $228.2 million in 2022, then rose by 12.44% to $256.6 million in 2023, then dropped by 23.98% to $195.0 million in 2024, then fell by 2.42% to $190.3 million in 2025, then dropped by 0.29% to $189.8 million in 2026.
- According to Business Quant data, Inventory Average over the past three periods registered $189.8 million, $190.3 million, and $178.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 14.14 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 14.39 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 5.00 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 6.56 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 6.57 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 6.21 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 1.84 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 10.66 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Amarin Corp Plcuk | 5.17 Bn | 5.00 Bn | 17.77 Mn | 189.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 189.76 Mn |
| Dec 31, 2025 | 190.31 Mn |
| Sep 30, 2025 | 177.95 Mn |
| Jun 30, 2025 | 165.35 Mn |
| Mar 31, 2025 | 162.77 Mn |
| Dec 31, 2024 | 195.02 Mn |
| Sep 30, 2024 | 231.70 Mn |
| Jun 30, 2024 | 247.34 Mn |
| Mar 31, 2024 | 256.95 Mn |
| Dec 31, 2023 | 256.56 Mn |
| Sep 30, 2023 | 240.76 Mn |
| Jun 30, 2023 | 226.42 Mn |
| Mar 31, 2023 | 227.27 Mn |
| Dec 31, 2022 | 228.17 Mn |
| Sep 30, 2022 | 226.70 Mn |
| Jun 30, 2022 | 246.81 Mn |
| Mar 31, 2022 | 251.25 Mn |
| Dec 31, 2021 | 271.99 Mn |
| Sep 30, 2021 | 290.90 Mn |
| Jun 30, 2021 | 251.70 Mn |